nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—PGR—Betamethasone—ankylosing spondylitis	0.251	0.494	CbGbCtD
Etonogestrel—PGR—Dexamethasone—ankylosing spondylitis	0.146	0.287	CbGbCtD
Etonogestrel—Danazol—Prednisone—ankylosing spondylitis	0.131	0.33	CrCrCtD
Etonogestrel—Methyltestosterone—Prednisone—ankylosing spondylitis	0.0932	0.236	CrCrCtD
Etonogestrel—Methyltestosterone—Prednisolone—ankylosing spondylitis	0.0909	0.23	CrCrCtD
Etonogestrel—Testosterone—Prednisolone—ankylosing spondylitis	0.081	0.205	CrCrCtD
Etonogestrel—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0275	0.0542	CbGbCtD
Etonogestrel—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0209	0.041	CbGbCtD
Etonogestrel—CYP3A4—Betamethasone—ankylosing spondylitis	0.0179	0.0352	CbGbCtD
Etonogestrel—CYP3A4—Prednisolone—ankylosing spondylitis	0.0177	0.0347	CbGbCtD
Etonogestrel—CYP3A4—Prednisone—ankylosing spondylitis	0.0167	0.0328	CbGbCtD
Etonogestrel—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0104	0.0205	CbGbCtD
Etonogestrel—Discomfort—Prednisolone—ankylosing spondylitis	0.000185	0.00192	CcSEcCtD
Etonogestrel—Angioedema—Triamcinolone—ankylosing spondylitis	0.000184	0.00192	CcSEcCtD
Etonogestrel—Haemoglobin—Prednisone—ankylosing spondylitis	0.000184	0.00191	CcSEcCtD
Etonogestrel—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000184	0.00191	CcSEcCtD
Etonogestrel—Haemorrhage—Prednisone—ankylosing spondylitis	0.000183	0.0019	CcSEcCtD
Etonogestrel—Erythema—Dexamethasone—ankylosing spondylitis	0.000183	0.0019	CcSEcCtD
Etonogestrel—Erythema—Betamethasone—ankylosing spondylitis	0.000183	0.0019	CcSEcCtD
Etonogestrel—Malaise—Triamcinolone—ankylosing spondylitis	0.000182	0.00189	CcSEcCtD
Etonogestrel—Malaise—Methylprednisolone—ankylosing spondylitis	0.000182	0.00189	CcSEcCtD
Etonogestrel—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00018	0.00187	CcSEcCtD
Etonogestrel—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000179	0.00186	CcSEcCtD
Etonogestrel—Oedema—Prednisolone—ankylosing spondylitis	0.000179	0.00186	CcSEcCtD
Etonogestrel—Dysuria—Methotrexate—ankylosing spondylitis	0.000179	0.00186	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000178	0.00185	CcSEcCtD
Etonogestrel—Cough—Triamcinolone—ankylosing spondylitis	0.000176	0.00183	CcSEcCtD
Etonogestrel—Convulsion—Triamcinolone—ankylosing spondylitis	0.000175	0.00182	CcSEcCtD
Etonogestrel—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000174	0.00181	CcSEcCtD
Etonogestrel—Hypertension—Triamcinolone—ankylosing spondylitis	0.000174	0.00181	CcSEcCtD
Etonogestrel—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000174	0.00181	CcSEcCtD
Etonogestrel—Myalgia—Triamcinolone—ankylosing spondylitis	0.000172	0.00179	CcSEcCtD
Etonogestrel—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000171	0.00178	CcSEcCtD
Etonogestrel—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000171	0.00178	CcSEcCtD
Etonogestrel—Eye disorder—Prednisone—ankylosing spondylitis	0.000171	0.00178	CcSEcCtD
Etonogestrel—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000171	0.00177	CcSEcCtD
Etonogestrel—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000171	0.00177	CcSEcCtD
Etonogestrel—Infestation—Methotrexate—ankylosing spondylitis	0.000171	0.00177	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00017	0.00177	CcSEcCtD
Etonogestrel—Depression—Methotrexate—ankylosing spondylitis	0.00017	0.00177	CcSEcCtD
Etonogestrel—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00017	0.00177	CcSEcCtD
Etonogestrel—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00017	0.00177	CcSEcCtD
Etonogestrel—Discomfort—Triamcinolone—ankylosing spondylitis	0.00017	0.00176	CcSEcCtD
Etonogestrel—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000169	0.00176	CcSEcCtD
Etonogestrel—Angioedema—Dexamethasone—ankylosing spondylitis	0.000167	0.00174	CcSEcCtD
Etonogestrel—Angioedema—Betamethasone—ankylosing spondylitis	0.000167	0.00174	CcSEcCtD
Etonogestrel—Angiopathy—Prednisone—ankylosing spondylitis	0.000166	0.00173	CcSEcCtD
Etonogestrel—Immune system disorder—Prednisone—ankylosing spondylitis	0.000165	0.00172	CcSEcCtD
Etonogestrel—Malaise—Betamethasone—ankylosing spondylitis	0.000165	0.00172	CcSEcCtD
Etonogestrel—Malaise—Dexamethasone—ankylosing spondylitis	0.000165	0.00172	CcSEcCtD
Etonogestrel—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000165	0.00171	CcSEcCtD
Etonogestrel—Oedema—Triamcinolone—ankylosing spondylitis	0.000165	0.00171	CcSEcCtD
Etonogestrel—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000164	0.00171	CcSEcCtD
Etonogestrel—Infection—Triamcinolone—ankylosing spondylitis	0.000164	0.0017	CcSEcCtD
Etonogestrel—Infection—Methylprednisolone—ankylosing spondylitis	0.000163	0.0017	CcSEcCtD
Etonogestrel—Insomnia—Prednisolone—ankylosing spondylitis	0.000162	0.00168	CcSEcCtD
Etonogestrel—Alopecia—Prednisone—ankylosing spondylitis	0.000162	0.00168	CcSEcCtD
Etonogestrel—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000161	0.00167	CcSEcCtD
Etonogestrel—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000161	0.00167	CcSEcCtD
Etonogestrel—Mental disorder—Prednisone—ankylosing spondylitis	0.00016	0.00167	CcSEcCtD
Etonogestrel—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00016	0.00166	CcSEcCtD
Etonogestrel—Malnutrition—Prednisone—ankylosing spondylitis	0.000159	0.00166	CcSEcCtD
Etonogestrel—Erythema—Prednisone—ankylosing spondylitis	0.000159	0.00166	CcSEcCtD
Etonogestrel—Convulsion—Dexamethasone—ankylosing spondylitis	0.000159	0.00165	CcSEcCtD
Etonogestrel—Convulsion—Betamethasone—ankylosing spondylitis	0.000159	0.00165	CcSEcCtD
Etonogestrel—Hypertension—Dexamethasone—ankylosing spondylitis	0.000158	0.00164	CcSEcCtD
Etonogestrel—Hypertension—Betamethasone—ankylosing spondylitis	0.000158	0.00164	CcSEcCtD
Etonogestrel—Myalgia—Dexamethasone—ankylosing spondylitis	0.000156	0.00162	CcSEcCtD
Etonogestrel—Myalgia—Betamethasone—ankylosing spondylitis	0.000156	0.00162	CcSEcCtD
Etonogestrel—Anxiety—Dexamethasone—ankylosing spondylitis	0.000155	0.00161	CcSEcCtD
Etonogestrel—Anxiety—Betamethasone—ankylosing spondylitis	0.000155	0.00161	CcSEcCtD
Etonogestrel—Discomfort—Dexamethasone—ankylosing spondylitis	0.000154	0.0016	CcSEcCtD
Etonogestrel—Discomfort—Betamethasone—ankylosing spondylitis	0.000154	0.0016	CcSEcCtD
Etonogestrel—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000154	0.0016	CcSEcCtD
Etonogestrel—Pain—Prednisolone—ankylosing spondylitis	0.000153	0.00159	CcSEcCtD
Etonogestrel—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000153	0.00159	CcSEcCtD
Etonogestrel—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000152	0.00158	CcSEcCtD
Etonogestrel—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000151	0.00157	CcSEcCtD
Etonogestrel—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00015	0.00156	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00015	0.00156	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00015	0.00156	CcSEcCtD
Etonogestrel—Oedema—Dexamethasone—ankylosing spondylitis	0.000149	0.00155	CcSEcCtD
Etonogestrel—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000149	0.00155	CcSEcCtD
Etonogestrel—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000149	0.00155	CcSEcCtD
Etonogestrel—Oedema—Betamethasone—ankylosing spondylitis	0.000149	0.00155	CcSEcCtD
Etonogestrel—Insomnia—Triamcinolone—ankylosing spondylitis	0.000149	0.00155	CcSEcCtD
Etonogestrel—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000149	0.00154	CcSEcCtD
Etonogestrel—Infection—Dexamethasone—ankylosing spondylitis	0.000148	0.00154	CcSEcCtD
Etonogestrel—Infection—Betamethasone—ankylosing spondylitis	0.000148	0.00154	CcSEcCtD
Etonogestrel—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000148	0.00154	CcSEcCtD
Etonogestrel—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000148	0.00154	CcSEcCtD
Etonogestrel—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000148	0.00153	CcSEcCtD
Etonogestrel—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000148	0.00153	CcSEcCtD
Etonogestrel—Visual impairment—Methotrexate—ankylosing spondylitis	0.000148	0.00153	CcSEcCtD
Etonogestrel—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000147	0.00152	CcSEcCtD
Etonogestrel—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000147	0.00152	CcSEcCtD
Etonogestrel—Angioedema—Prednisone—ankylosing spondylitis	0.000146	0.00151	CcSEcCtD
Etonogestrel—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000145	0.00151	CcSEcCtD
Etonogestrel—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000145	0.0015	CcSEcCtD
Etonogestrel—Malaise—Prednisone—ankylosing spondylitis	0.000144	0.00149	CcSEcCtD
Etonogestrel—Eye disorder—Methotrexate—ankylosing spondylitis	0.000143	0.00149	CcSEcCtD
Etonogestrel—Anorexia—Dexamethasone—ankylosing spondylitis	0.000142	0.00148	CcSEcCtD
Etonogestrel—Anorexia—Betamethasone—ankylosing spondylitis	0.000142	0.00148	CcSEcCtD
Etonogestrel—Urticaria—Prednisolone—ankylosing spondylitis	0.000142	0.00148	CcSEcCtD
Etonogestrel—Fatigue—Triamcinolone—ankylosing spondylitis	0.000142	0.00148	CcSEcCtD
Etonogestrel—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000142	0.00147	CcSEcCtD
Etonogestrel—Pain—Triamcinolone—ankylosing spondylitis	0.000141	0.00146	CcSEcCtD
Etonogestrel—Angiopathy—Methotrexate—ankylosing spondylitis	0.000139	0.00144	CcSEcCtD
Etonogestrel—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000138	0.00144	CcSEcCtD
Etonogestrel—Convulsion—Prednisone—ankylosing spondylitis	0.000138	0.00144	CcSEcCtD
Etonogestrel—Hypertension—Prednisone—ankylosing spondylitis	0.000138	0.00143	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000136	0.00141	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000136	0.00141	CcSEcCtD
Etonogestrel—Arthralgia—Prednisone—ankylosing spondylitis	0.000136	0.00141	CcSEcCtD
Etonogestrel—Myalgia—Prednisone—ankylosing spondylitis	0.000136	0.00141	CcSEcCtD
Etonogestrel—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000136	0.00141	CcSEcCtD
Etonogestrel—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000135	0.00141	CcSEcCtD
Etonogestrel—Anxiety—Prednisone—ankylosing spondylitis	0.000135	0.00141	CcSEcCtD
Etonogestrel—Alopecia—Methotrexate—ankylosing spondylitis	0.000135	0.00141	CcSEcCtD
Etonogestrel—Insomnia—Betamethasone—ankylosing spondylitis	0.000135	0.0014	CcSEcCtD
Etonogestrel—Insomnia—Dexamethasone—ankylosing spondylitis	0.000135	0.0014	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000135	0.0014	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000134	0.0014	CcSEcCtD
Etonogestrel—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000134	0.00139	CcSEcCtD
Etonogestrel—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000134	0.00139	CcSEcCtD
Etonogestrel—Discomfort—Prednisone—ankylosing spondylitis	0.000134	0.00139	CcSEcCtD
Etonogestrel—Mental disorder—Methotrexate—ankylosing spondylitis	0.000134	0.00139	CcSEcCtD
Etonogestrel—Malnutrition—Methotrexate—ankylosing spondylitis	0.000133	0.00138	CcSEcCtD
Etonogestrel—Erythema—Methotrexate—ankylosing spondylitis	0.000133	0.00138	CcSEcCtD
Etonogestrel—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000132	0.00137	CcSEcCtD
Etonogestrel—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000132	0.00137	CcSEcCtD
Etonogestrel—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000132	0.00137	CcSEcCtD
Etonogestrel—Urticaria—Triamcinolone—ankylosing spondylitis	0.000131	0.00136	CcSEcCtD
Etonogestrel—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000131	0.00136	CcSEcCtD
Etonogestrel—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00013	0.00135	CcSEcCtD
Etonogestrel—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00013	0.00135	CcSEcCtD
Etonogestrel—Oedema—Prednisone—ankylosing spondylitis	0.00013	0.00135	CcSEcCtD
Etonogestrel—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00013	0.00135	CcSEcCtD
Etonogestrel—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00013	0.00135	CcSEcCtD
Etonogestrel—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00013	0.00135	CcSEcCtD
Etonogestrel—Infection—Prednisone—ankylosing spondylitis	0.000129	0.00134	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000129	0.00134	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000129	0.00134	CcSEcCtD
Etonogestrel—Back pain—Methotrexate—ankylosing spondylitis	0.000129	0.00134	CcSEcCtD
Etonogestrel—Fatigue—Betamethasone—ankylosing spondylitis	0.000129	0.00134	CcSEcCtD
Etonogestrel—Fatigue—Dexamethasone—ankylosing spondylitis	0.000129	0.00134	CcSEcCtD
Etonogestrel—Pain—Dexamethasone—ankylosing spondylitis	0.000128	0.00133	CcSEcCtD
Etonogestrel—Pain—Betamethasone—ankylosing spondylitis	0.000128	0.00133	CcSEcCtD
Etonogestrel—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000128	0.00133	CcSEcCtD
Etonogestrel—Skin disorder—Prednisone—ankylosing spondylitis	0.000126	0.00131	CcSEcCtD
Etonogestrel—Anorexia—Prednisone—ankylosing spondylitis	0.000124	0.00129	CcSEcCtD
Etonogestrel—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000124	0.00128	CcSEcCtD
Etonogestrel—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000123	0.00128	CcSEcCtD
Etonogestrel—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000123	0.00128	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000122	0.00127	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000122	0.00127	CcSEcCtD
Etonogestrel—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000121	0.00126	CcSEcCtD
Etonogestrel—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000121	0.00126	CcSEcCtD
Etonogestrel—Malaise—Methotrexate—ankylosing spondylitis	0.00012	0.00125	CcSEcCtD
Etonogestrel—Urticaria—Dexamethasone—ankylosing spondylitis	0.000119	0.00123	CcSEcCtD
Etonogestrel—Urticaria—Betamethasone—ankylosing spondylitis	0.000119	0.00123	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000119	0.00123	CcSEcCtD
Etonogestrel—Dizziness—Prednisolone—ankylosing spondylitis	0.000118	0.00123	CcSEcCtD
Etonogestrel—Asthenia—Triamcinolone—ankylosing spondylitis	0.000118	0.00123	CcSEcCtD
Etonogestrel—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000118	0.00123	CcSEcCtD
Etonogestrel—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000118	0.00123	CcSEcCtD
Etonogestrel—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000118	0.00123	CcSEcCtD
Etonogestrel—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000118	0.00123	CcSEcCtD
Etonogestrel—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000118	0.00123	CcSEcCtD
Etonogestrel—Insomnia—Prednisone—ankylosing spondylitis	0.000118	0.00122	CcSEcCtD
Etonogestrel—Paraesthesia—Prednisone—ankylosing spondylitis	0.000117	0.00121	CcSEcCtD
Etonogestrel—Pruritus—Triamcinolone—ankylosing spondylitis	0.000117	0.00121	CcSEcCtD
Etonogestrel—Cough—Methotrexate—ankylosing spondylitis	0.000116	0.00121	CcSEcCtD
Etonogestrel—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000116	0.00121	CcSEcCtD
Etonogestrel—Convulsion—Methotrexate—ankylosing spondylitis	0.000115	0.0012	CcSEcCtD
Etonogestrel—Dyspepsia—Prednisone—ankylosing spondylitis	0.000115	0.00119	CcSEcCtD
Etonogestrel—Myalgia—Methotrexate—ankylosing spondylitis	0.000113	0.00118	CcSEcCtD
Etonogestrel—Arthralgia—Methotrexate—ankylosing spondylitis	0.000113	0.00118	CcSEcCtD
Etonogestrel—Decreased appetite—Prednisone—ankylosing spondylitis	0.000113	0.00118	CcSEcCtD
Etonogestrel—Rash—Prednisolone—ankylosing spondylitis	0.000113	0.00117	CcSEcCtD
Etonogestrel—Dermatitis—Prednisolone—ankylosing spondylitis	0.000113	0.00117	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000113	0.00117	CcSEcCtD
Etonogestrel—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000112	0.00117	CcSEcCtD
Etonogestrel—Fatigue—Prednisone—ankylosing spondylitis	0.000112	0.00117	CcSEcCtD
Etonogestrel—Headache—Prednisolone—ankylosing spondylitis	0.000112	0.00117	CcSEcCtD
Etonogestrel—Discomfort—Methotrexate—ankylosing spondylitis	0.000112	0.00116	CcSEcCtD
Etonogestrel—Constipation—Prednisone—ankylosing spondylitis	0.000111	0.00116	CcSEcCtD
Etonogestrel—Dizziness—Triamcinolone—ankylosing spondylitis	0.000109	0.00113	CcSEcCtD
Etonogestrel—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000109	0.00113	CcSEcCtD
Etonogestrel—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000109	0.00113	CcSEcCtD
Etonogestrel—Infection—Methotrexate—ankylosing spondylitis	0.000108	0.00112	CcSEcCtD
Etonogestrel—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000107	0.00111	CcSEcCtD
Etonogestrel—Asthenia—Betamethasone—ankylosing spondylitis	0.000107	0.00111	CcSEcCtD
Etonogestrel—Asthenia—Dexamethasone—ankylosing spondylitis	0.000107	0.00111	CcSEcCtD
Etonogestrel—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000107	0.00111	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000106	0.00111	CcSEcCtD
Etonogestrel—Nausea—Prednisolone—ankylosing spondylitis	0.000106	0.00111	CcSEcCtD
Etonogestrel—Pruritus—Betamethasone—ankylosing spondylitis	0.000106	0.0011	CcSEcCtD
Etonogestrel—Pruritus—Dexamethasone—ankylosing spondylitis	0.000106	0.0011	CcSEcCtD
Etonogestrel—Skin disorder—Methotrexate—ankylosing spondylitis	0.000106	0.0011	CcSEcCtD
Etonogestrel—Vomiting—Triamcinolone—ankylosing spondylitis	0.000105	0.00109	CcSEcCtD
Etonogestrel—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000104	0.00109	CcSEcCtD
Etonogestrel—Rash—Triamcinolone—ankylosing spondylitis	0.000104	0.00108	CcSEcCtD
Etonogestrel—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000104	0.00108	CcSEcCtD
Etonogestrel—Anorexia—Methotrexate—ankylosing spondylitis	0.000104	0.00108	CcSEcCtD
Etonogestrel—Rash—Methylprednisolone—ankylosing spondylitis	0.000104	0.00108	CcSEcCtD
Etonogestrel—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000104	0.00108	CcSEcCtD
Etonogestrel—Urticaria—Prednisone—ankylosing spondylitis	0.000103	0.00107	CcSEcCtD
Etonogestrel—Headache—Triamcinolone—ankylosing spondylitis	0.000103	0.00107	CcSEcCtD
Etonogestrel—Headache—Methylprednisolone—ankylosing spondylitis	0.000103	0.00107	CcSEcCtD
Etonogestrel—Abdominal pain—Prednisone—ankylosing spondylitis	0.000103	0.00107	CcSEcCtD
Etonogestrel—Body temperature increased—Prednisone—ankylosing spondylitis	0.000103	0.00107	CcSEcCtD
Etonogestrel—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000102	0.00106	CcSEcCtD
Etonogestrel—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000102	0.00106	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	9.91e-05	0.00103	CcSEcCtD
Etonogestrel—Dizziness—Dexamethasone—ankylosing spondylitis	9.88e-05	0.00103	CcSEcCtD
Etonogestrel—Dizziness—Betamethasone—ankylosing spondylitis	9.88e-05	0.00103	CcSEcCtD
Etonogestrel—Insomnia—Methotrexate—ankylosing spondylitis	9.84e-05	0.00102	CcSEcCtD
Etonogestrel—Nausea—Triamcinolone—ankylosing spondylitis	9.78e-05	0.00102	CcSEcCtD
Etonogestrel—Paraesthesia—Methotrexate—ankylosing spondylitis	9.76e-05	0.00101	CcSEcCtD
Etonogestrel—Nausea—Methylprednisolone—ankylosing spondylitis	9.76e-05	0.00101	CcSEcCtD
Etonogestrel—Somnolence—Methotrexate—ankylosing spondylitis	9.67e-05	0.001	CcSEcCtD
Etonogestrel—Hypersensitivity—Prednisone—ankylosing spondylitis	9.59e-05	0.000996	CcSEcCtD
Etonogestrel—Dyspepsia—Methotrexate—ankylosing spondylitis	9.57e-05	0.000995	CcSEcCtD
Etonogestrel—Vomiting—Betamethasone—ankylosing spondylitis	9.5e-05	0.000987	CcSEcCtD
Etonogestrel—Vomiting—Dexamethasone—ankylosing spondylitis	9.5e-05	0.000987	CcSEcCtD
Etonogestrel—Decreased appetite—Methotrexate—ankylosing spondylitis	9.45e-05	0.000982	CcSEcCtD
Etonogestrel—Rash—Betamethasone—ankylosing spondylitis	9.42e-05	0.000979	CcSEcCtD
Etonogestrel—Rash—Dexamethasone—ankylosing spondylitis	9.42e-05	0.000979	CcSEcCtD
Etonogestrel—Dermatitis—Betamethasone—ankylosing spondylitis	9.41e-05	0.000978	CcSEcCtD
Etonogestrel—Dermatitis—Dexamethasone—ankylosing spondylitis	9.41e-05	0.000978	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	9.39e-05	0.000976	CcSEcCtD
Etonogestrel—Fatigue—Methotrexate—ankylosing spondylitis	9.38e-05	0.000974	CcSEcCtD
Etonogestrel—Headache—Betamethasone—ankylosing spondylitis	9.36e-05	0.000973	CcSEcCtD
Etonogestrel—Headache—Dexamethasone—ankylosing spondylitis	9.36e-05	0.000973	CcSEcCtD
Etonogestrel—Asthenia—Prednisone—ankylosing spondylitis	9.34e-05	0.00097	CcSEcCtD
Etonogestrel—Pain—Methotrexate—ankylosing spondylitis	9.3e-05	0.000966	CcSEcCtD
Etonogestrel—Pruritus—Prednisone—ankylosing spondylitis	9.21e-05	0.000957	CcSEcCtD
Etonogestrel—Feeling abnormal—Methotrexate—ankylosing spondylitis	8.96e-05	0.000931	CcSEcCtD
Etonogestrel—Diarrhoea—Prednisone—ankylosing spondylitis	8.9e-05	0.000925	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	8.89e-05	0.000924	CcSEcCtD
Etonogestrel—Nausea—Dexamethasone—ankylosing spondylitis	8.88e-05	0.000922	CcSEcCtD
Etonogestrel—Nausea—Betamethasone—ankylosing spondylitis	8.88e-05	0.000922	CcSEcCtD
Etonogestrel—Urticaria—Methotrexate—ankylosing spondylitis	8.64e-05	0.000898	CcSEcCtD
Etonogestrel—Dizziness—Prednisone—ankylosing spondylitis	8.6e-05	0.000894	CcSEcCtD
Etonogestrel—Body temperature increased—Methotrexate—ankylosing spondylitis	8.6e-05	0.000893	CcSEcCtD
Etonogestrel—Abdominal pain—Methotrexate—ankylosing spondylitis	8.6e-05	0.000893	CcSEcCtD
Etonogestrel—Vomiting—Prednisone—ankylosing spondylitis	8.27e-05	0.00086	CcSEcCtD
Etonogestrel—Rash—Prednisone—ankylosing spondylitis	8.2e-05	0.000853	CcSEcCtD
Etonogestrel—Dermatitis—Prednisone—ankylosing spondylitis	8.2e-05	0.000852	CcSEcCtD
Etonogestrel—Headache—Prednisone—ankylosing spondylitis	8.15e-05	0.000847	CcSEcCtD
Etonogestrel—Hypersensitivity—Methotrexate—ankylosing spondylitis	8.01e-05	0.000833	CcSEcCtD
Etonogestrel—Asthenia—Methotrexate—ankylosing spondylitis	7.8e-05	0.000811	CcSEcCtD
Etonogestrel—Nausea—Prednisone—ankylosing spondylitis	7.73e-05	0.000803	CcSEcCtD
Etonogestrel—Pruritus—Methotrexate—ankylosing spondylitis	7.69e-05	0.0008	CcSEcCtD
Etonogestrel—Diarrhoea—Methotrexate—ankylosing spondylitis	7.44e-05	0.000773	CcSEcCtD
Etonogestrel—Dizziness—Methotrexate—ankylosing spondylitis	7.19e-05	0.000747	CcSEcCtD
Etonogestrel—Vomiting—Methotrexate—ankylosing spondylitis	6.91e-05	0.000719	CcSEcCtD
Etonogestrel—Rash—Methotrexate—ankylosing spondylitis	6.86e-05	0.000713	CcSEcCtD
Etonogestrel—Dermatitis—Methotrexate—ankylosing spondylitis	6.85e-05	0.000712	CcSEcCtD
Etonogestrel—Headache—Methotrexate—ankylosing spondylitis	6.81e-05	0.000708	CcSEcCtD
Etonogestrel—Nausea—Methotrexate—ankylosing spondylitis	6.46e-05	0.000671	CcSEcCtD
